Australia markets closed

McKesson Corporation (MCK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
321.55-4.69 (-1.44%)
At close: 04:04PM EDT
321.50 -0.05 (-0.02%)
After hours: 07:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close326.24
Open327.47
Bid0.00 x 1000
Ask0.00 x 1200
Day's range319.67 - 329.17
52-week range186.61 - 339.94
Volume828,884
Avg. volume1,192,893
Market cap46.168B
Beta (5Y monthly)0.66
PE ratio (TTM)44.29
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.88 (0.58%)
Ex-dividend date31 May 2022
1y target estN/A
  • Business Wire

    McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research

    IRVING, Texas & NASHVILLE, Tenn., June 23, 2022--McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI). USOR is the research arm of McKesson’s The US Oncology Network and draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials. SCRI, which is the research

  • Business Wire

    McKesson Reports Fiscal 2022 Fourth-Quarter Results

    IRVING, Texas, May 05, 2022--McKesson Corporation (NYSE: MCK) has released its fiscal 2022 fourth-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.

  • Business Wire

    Distributors Agree to Opioid Settlement With Washington State

    CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas, May 03, 2022--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement with the Washington Attorney General, under which the distributors will pay up to $518 million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with Washington’s allocation under the previously announced comprehensive agreement